GNH USA

Europe — EMA

Mometazon Doppelherz (Mometasone Furoate Monohydrate)

GNH USA supplies Mometazon Doppelherz (Mometasone Furoate), a nasal corticosteroid for allergic rhinitis and nasal polyps. Request a quote for global supply.

Request sourcing

1
Pack/s

What is Mometasone Furoate Monohydrate?

Mometasone furoate, the active ingredient in Mometazon Doppelherz, is a corticosteroid presented as a nasal spray for intranasal use. It reduces inflammation in the nasal passages and is employed to treat allergic rhinitis and nasal polyps in adults and children. It is indicated for both seasonal and perennial forms of allergic rhinitis and may be used as part of a comprehensive allergy management plan.

GNH USA supplies Mometazon Doppelherz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution.

What is Mometasone Furoate Monohydrate used for?

Mometasone furoate nasal spray is used to manage inflammatory conditions of the nasal mucosa.

- Allergic rhinitis: alleviates nasal congestion, itching and sneezing caused by seasonal or perennial allergens. - Nasal polyps: reduces polyp size and improves nasal airflow after surgical removal. - Non‑allergic rhinitis: decreases inflammation and nasal discharge in irritant‑induced rhinitis.

What are the side effects of Mometasone Furoate Monohydrate?

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning - Dryness of nasal passages - Epistaxis (nosebleed) - Headache

Serious or Rare Side Effects: - Nasal septal perforation - Cataracts or glaucoma with prolonged use - Adrenal suppression or systemic corticosteroid effects

What precautions apply to Mometasone Furoate Monohydrate?

When using Mometasone furoate nasal spray, consider the following precautions.

- Pregnancy: consult a healthcare professional before use, as safety data are limited. - Children under 2 years: generally not recommended unless specifically prescribed. - Concurrent systemic corticosteroids: monitor for additive glucocorticoid effects. - History of nasal surgery or septal perforation: use with caution. - Infection: avoid use if active nasal or sinus infection is present without medical advice. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

What does Mometasone Furoate Monohydrate interact with?

Mometasone furoate nasal spray can interact with certain medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid side effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local drug exposure.

Moderate Interactions (Monitor Closely): - Antihistamines: may increase nasal dryness or irritation. - Decongestant nasal sprays: concurrent use may affect absorption and increase local irritation. - Live vaccines: potential reduced efficacy due to immunosuppression.

Frequently asked questions

What conditions is Mometazon Doppelherz used for?+
Mometazon Doppelherz contains mometasone furoate, a nasal corticosteroid that is prescribed to treat inflammatory nasal conditions such as allergic rhinitis, nasal polyps after surgery, and non‑allergic rhinitis. It works by reducing swelling and irritation within the nasal passages, helping to relieve symptoms like congestion, sneezing, and runny nose.
How does mometasone furoate work in the nose?+
Mometasone furoate binds to glucocorticoid receptors inside nasal epithelial cells. The drug‑receptor complex moves into the cell nucleus and alters gene expression, suppressing the release of inflammatory cytokines, chemokines, and other mediators. This reduces vascular leakage, edema, and the recruitment of inflammatory cells, leading to decreased nasal inflammation.
What is the usual dose of Mometazon Doppelherz?+
The specific dose and frequency of Mometazon Doppelherz are determined by the prescribing healthcare professional based on the patient’s age, condition severity, and response to therapy. Patients should follow the prescriber’s instructions and the product label; no universal dosing regimen is provided here.
Is Mometazon Doppelherz safe during pregnancy or breastfeeding?+
Safety data for mometasone furoate nasal spray in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.
How do I order Mometazon Doppelherz from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does Mometazon Doppelherz compare with other nasal steroids?+
Mometasone furoate is a high‑potency intranasal corticosteroid with a low systemic absorption profile, similar to other agents such as fluticasone propionate and budesonide. Compared with lower‑potency options, it may achieve symptom control at a lower daily dose, but individual response and tolerability can vary, so clinicians choose based on patient needs.
What are the recommended storage conditions for Mometazon Doppelherz?+
Mometazon Doppelherz should be stored at room temperature, typically below 25 °C (77 °F). Keep the spray in its original packaging, protect it from moisture, excessive heat, and direct sunlight to maintain product stability and potency.
How is Mometazon Doppelherz administered?+
The product is a nasal spray intended for intranasal use. The patient should gently blow the nose, tilt the head slightly forward, insert the nozzle into one nostril, and spray the prescribed number of sprays while breathing in gently. The process is repeated in the other nostril if directed by the prescriber.
What are the most serious risks associated with Mometazon Doppelherz?+
Serious but rare risks include nasal septal perforation, cataracts or glaucoma with long‑term use, and systemic effects such as adrenal suppression, especially when used together with other systemic corticosteroids. Patients should report any unusual visual changes, persistent nosebleeds, or signs of hormonal imbalance to their healthcare provider promptly.
Who should not use Mometazon Doppelherz?+
Mometazon Doppelherz is contraindicated in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It should also be avoided in patients with active untreated nasal infections, recent nasal surgery involving the septum, or those for whom intranasal corticosteroids are deemed inappropriate by their clinician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Mometasone Furoate Monohydrate
Route
Nasal Use
Manufacturer
Doppelherz Pharma Gmbh
Origin
EU

Related products